More on CLVLY
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $6.20 |
|
|||
| Open | $6.62 | ||||
| 52 Wk High | $6.92 | ||||
| 52 Wk Low | $1.79 | ||||
| Day High | $6.62 | ||||
| Day Low | $6.62 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 121 | ||||
- CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study
- CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026
- CLINUVEL to advance novel pharmaceutical formulations in preclinical program
- CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist
Entities mentioned with CLVLY
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Macquarie Group | View Related Stories »
- PDUFA | View Related Stories »
- AdCom | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Vanguard | View Related Stories »
- Show More...
